The total return for Vertex Pharmaceuticals Incorporated (VRTX) stock is -0.09% over the past 12 months vs. +24.34% for the S&P 500. So far it's up -1.67% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (0.09%) | +10.09% | +15.86% | +17.03% | +16.01% | +14.08% |
| Total Return CAGR | (0.09%) | +10.09% | +15.86% | +17.03% | +16.01% | +14.08% |
| Revenue CAGR | +10.42% | +10.00% | +13.82% | +25.23% | +31.81% | +23.80% |
| Net Income CAGR | +3.89% | +9.99% | +9.45% | +29.85% | - | - |
| EPS CAGR | +4.89% | +6.03% | +8.17% | +39.93% | - | - |
| Free Cash Flow CAGR | +2.42% | (1.57%) | +4.01% | +56.82% | - | - |
| Operating Cash Flow CAGR | +3.69% | +1.35% | +4.77% | +36.56% | - | - |
| Dividends CAGR | - | - | - | - | - | - |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Vertex Pharmaceuticals Incorporated (VRTX)
| Year | Start Value | End Value | VRTX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | 2467.27 | 2425.96 | (1.67%) | +8.38% | (10.05%) |
| 2025 | 2191.56 | 2467.27 | +12.58% | +17.72% | (5.14%) |
| 2024 | 2214.37 | 2191.56 | (1.03%) | +24.89% | (25.92%) |
| 2023 | 1571.59 | 2214.37 | +40.90% | +26.19% | +14.71% |
| 2022 | 1195.10 | 1571.59 | +31.50% | (18.17%) | +49.67% |
| 2021 | 1286.20 | 1195.10 | (7.08%) | +28.74% | (35.82%) |
| 2020 | 1191.56 | 1286.20 | +7.94% | +18.37% | (10.43%) |
| 2019 | 901.82 | 1191.56 | +32.13% | +31.22% | +0.91% |
| 2018 | 815.56 | 901.82 | +10.58% | (4.56%) | +15.14% |
| 2017 | 400.93 | 815.56 | +103.42% | +21.70% | +81.72% |
